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Systemic hypertension isthe most common cardiovascular 
condition observed in competitive athletes. The diagnosis of 
hypertension is based on the presence of blood pressure 
persistently at or above certain levels as measured by routine 
sphygmomanometry on at least hree separate occasions (Ta- 
ble 1). In determining the level of competitive athletic activity 
that a hypertensive p rson may assume, it is also important to 
ascertain the degree of hypertension-related target organ 
damage (1). Although hypertension is associated with an 
increased risk for sudden death and complex ventricular 
arrhythmias (2), this disease has not yet been incriminated as a 
cause of sudden cardiac death in young competitive athletes 
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T&M 1. &&ication of Hypertension by Age in Children 
and Adolescents 
Magnitude of Hypertension* 
Mild Moderate Severe Very Severe 
(stage 1) (stage 2) (stage 3) (stage 4) 
(mm Hg) (mm Hg) (mm Hg) (mm Hg) 
Children 
6-9 yr oldt 
Systolii BP 120-124 125-129 130-139 z140 
Diastolic BP 75-79 80-84 85-89 =90 
IO-12 yr oldt 
Systolic BP U-129 130-134 135-144 214s 
Diastalic BP 80-M X5-89 90-94 295 
Adolescents 
13-15 yr oldt 
Systolic BP 135-139 140-149 150-159 Z168 
Diastolic BP 85-89 90-94 95-99 2 lOl1 
16-18 yr oldt 
Systolic BP MO-149 150-159 160-179 blXO 
Diastolic BP W-94 95-99 100-199 2110 
Adults 
$18 yr old+ 
Systolic BP MO-159 160-179 180-209 r210 
Diastolic BP 90-99 RJO-109 110-119 2120 
‘Applies to patients who are not taking antihypertensive drugs and are ni 
acutely ill. When the systolic and diastolic blood pressures (BP) fall into different 
categories, the higher categoty should be selected to classify that patient’s blood 
pressure status, In adults, isolated systolic hypertension is defined as a systolic 
blood pressure ~148 mm Hg and a diastolic blood pressure <90 mm Hg and 
staged appropriately. Blood pressure values are based on the average of three or 
more readings taken at each of two or more visits after the initial screening. 
tAdapted from the recommendations of the Second Task Force on Blood 
Pressure Control in Children (Pediatrics 198?79:1-2.5) to be consistent with the 
classificalion in adults. *From the Fifth Report of the Joint National Committee 
on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch 
Intern Med 1993;153:154-83. 
(34). Consequently, most of the following considerations 
pertain to the effects of training and competition on the 
progression f hypertension. 
Ekes of exercise. The possibility exists that he immediate 
pressor effect of strenuous static activity may be harmful and is 
based largely on a few reports (5) of cerebrovascular accidents 
during maximal effort. However, there is increasing evidence 
that pure static (6) or combined static and dynamic activity, as 
provided by circuit rainin (7), may in fact produce a long- 
term antihypertensive eff ct. African-Americans may have a 
greater pressor response during dynamic exercise than non- 
blacks (8,9). However, there are no data to implicate a less 
long-term benefit or increased cardiovascular risk from exer- 
cise in this population. 
In contrast, an impressive body of data (10,ll) is available 
that documents an antihypertensive eff ct from repetitive 
dynamic physical ctivity. Although multiple mechanisms are 
probably responsible (12), it is worth emphasizing that exercise 
may normalize blood pressure in some people with mildly 
elevated levels (13). 
All those with hypertension who wish to engage incompet- 
itive athletics should increase activity levels gradually so as to 
avoid the cardiac catastrophes s en in sedentary people who 
undertake major bursts of strenuous exercise (14). Because the 
risk of myocardial infarction per unit time appears to be 
modestly increased during intense xercise, ven in those who 
are well conditioned (14), an exercise t st may be appropriate 
for hypertensive athletes with other coronary risk factors who 
are >35 years old. 
Untreated hyperterrsion n athletes may be accompanied 
by some limitation i exercise performance (15). Before initi- 
ating drug therapy, athletes hould be strongly encouraged 
to adopt healthy life-style behavior and avoid the fol\*Jwing: 
tobacco in any form, excess alcohol, drugs of abuse (especially 
cocaine), androgens, growth ormones and high sodium in- 
take. The use of antihypertensive drugs may further limit 
exercise capacity, more so with beta-adrenergic receptor block- 
ing agents than with vasodilators (alpha-adrenergic blo king 
agents, angiotcnsin-converting enzyme inhibitors or calcium 
channel blocking agents) (16). Nowever, performance may bc 
enhanced by reduction ofelevated blood pressure and curtail- 
ment of exercise-induced hypertensive responses with well 
tolerated antihypertensive medications. It is advised that the 
use of diuretic drugs and beta-blockers by competitive athletes 
has been prohibited by some athletic governing bodies. 
Evaluation. Blood pressure should be accurately measured 
in all who wish to compete incompetitive athletics, preferably 
before they begin training. Blood pressure should be measured 
by routine sphygmomanometty, using the guidelines li ted in 
Table 2 (17). Caution is needed to avoid “white-coat” eleva- 
tions induced by the anxiety of the examination, particularly in 
a young person concerned about he examination. If feasible, 
additiona! blood pressure r cordings outside the office could 
be obtained in those with high office readings, either with 
readily available inexpensive home self-recorders (after the 
accuracy of their use has been validated) orwith less accessible 
and more expensive automatic ambulatory monitors. 
Considerable anxiety and, thereby, further elevations in
blood pressure may follow the initial recognition f an elevated 
blood pressure. Therefore, unless the blood pressure is se- 
verely elevated (Table l), the subject should be advised that 
the initial reading issomewhat elevated but may decrease on 
repeated measurements and that there is no reason to be 
concerned until more measurements aretaken. 
Those with any degree of persistent hypertension should 
have a thorough istory and physical examination (17) and 
limited laboratory testing to evaluate s condary causes and for 
target organ damage. The laboratory testing for most subjects 
observed tohave mild to moderate (stages 1 and 2) hyperten- 
sion should be limited to an automated blood chemistry 
(glucose, creatinine, lectrolytes, cholesterol), hematocrit, 
urine analysis and an electrocardiogram. If the results of these 
are abnormal, orif features suggestive of secondary causes are 
noted by history or physical examination (17), the subject 
should be referred for additional study and therapy. 
%o additional studies, echocardiography andexercise- 
stress testing, may be useful. However, because ofthe expense 
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Posture 
Blood pressure obtained in the sitting position is recommended. The subject should sit quietly for 5 min, with the 
back supported and the arm supported at the level of the heart, before recording blood pressure 
Circumstances 
No caffeine during the hour preceding the reading 
No smoking during the 30 min preceding the reading 
A quiet, warm setting 
Equipment 
Cuff size 
The bladder should encircle and cover hvo-thirds of the length of the arm; if it does not, place the bladder over 
the brachial artery. If bladder is too short, misleadingly high readings may result 
Manometer 
Aneroid gauges should be calibrated every 6 mo against a mercury manometer 
Technique 
No. of readings 
On each occasion, take at least two readings, separated hy as much time as is practical. If readings vary by 
Xi mm Hg, take additional readings until two consecutive readings are close 
If the iaihl values arc elevated, obtain two other sets of readings at least I week apart 
Initially, take pressure in both arms; if the pressures differ, use tbc arm with lhe higher pressure 
If the arm pressore is cleva(ed, take lhc pressure in or.e leg (particularly in patients ~30 yr old) 
Performance 
Inl!ate the bladder quickly to a prcsslnrc 20 mm 116 abov!~ the systolic pressure, as rer:)gnizcd by disappcaraoce 
of the radial pulse 
Deflate the bladder 3 mm Hgls 
Record the Korotkoff phase V (disappearance), except in children, in whom use of phase IV (muffling) may be 
preferable when disappearance of the sounds is not perceived. 
If the Korotkoff sounds are weak, have the patient raise the arm, open and close the hand 5 to IO times and 
then reinflate the bladder quickly 
Recordings 
Blood pressure, patient position and arm and cuff size 
and the absence ofdata documenting that hey provide ither 
diagnostic or prognostic information abouf the eiigibiirityfor athletic 
competition in relation to hypertension, they are not required for 
routine use. In those subjects in whom an exercise t st is 
performed for other easons, a marked increase in systolic blood 
pressure (>240 mm Hg) may presage the development of hyper- 
tension under basal conditions and indicate he need for further 
investigation and antihypertensive therapy. An increase in dia- 
stolic pressure is generally evidence for increased peripheral 
resistance. If an echocardiogram is performed, the presence of 
significant concentric hypertrophy is an important risk factor in 
adults (18) and may indicate the need for antihypertensive 
therapy, even at blood pressure levels that might not otherwise b
high enough to mandate herapy. 
Types of Hypertension 
Because -95% of all systemic hypertension is primary 
(essential), wehave made no distinction i this report between 
primary and secondary etiologies of increased blood pressure. 
Obviously, if secondary forms of hypertension are identified, 
these should be appropriately managed. 
Recommendatiolls 
1. The presence of mild to moderate (stages 1 and 2) hyper- 
tension (as defined in Table 1) in the absence of target organ 
damage orconcomitant heart disease hould not limit he eligi- 
bility for any competitive sports. Because there are in fact 
documented benefits from moderate dynamic and static exercise 
in lowering the blood pressure and improj ing other coronary isk 
factors (I), a persuasive argument can be made for hypertensive 
subjects oengage in regular forms of exercise. Once having 
begun atraining program, the hypertensive athlete should have 
blood pressure measured very 2to 4 months or more fre- 
quently, if indicated, to monitor the impact of exercise. 
2. Athletes with severe hypertension (stages 3 and 4) should 
be restricted, particularlv from high static sports (classes IIIA to 
IIIC [see Table 1 in Classification of Sports]), until their hyper- 
t nsion is controlled by either life-style modification r drug 
therapy (and in the absence of evidence of target organ damage). 
Because competitive athletics may demand more strenuous exer- 
cise than is needed for cardiovascular conditioning, these restric- 
tions are appropriate forthose with relatively severe hypcrten- 
sion, particularly if target organ damage is present. Despite the 
apparent logic of this position, it should be emphasized that here 
are few data documenting that strenuous dynamic exercise among 
even the most severely hypertensive subjects enhances ri k for 
sudden cardiac death or progression of their hypertensive disease 
(3,4,19). 
3. When hypertension coexists with other cardiovascular 
diseases, eligibility for participation in competitive athletics i  
usually based on the type and severity ofthe other associated 
conditions. 
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Tk most frequent cause of exercise-related car iac events 
and sudden death in adults is atherosclerotic coronary artery 
diiase (1). Furthermore, the incidence ofmyocardial nfarc- 
tion (2,3), cardiac arrest (4) and sudden cardiac death (1) 
increases transiently during vigorous physical ctivity. Insome 
studies, a sign&ant proportion of adult victims of exercise- 
related sudden death ad known coronary artery disease (1). 
Therefore, it is likely that he risk of exercise-related cardiac 
events in patients with previously diagnosed coronary artcry 
diiase is higher than that in apparently healthy subjects. 
Necropsy examination f adult victims of exercise-related 
sudden death usually reveals either advanced coronary artery 
stenosis oran acute coronary artery lesion, or bo:h ($6). This 
observation suggests hat exercise-related su den death can 
result from either exercise-induced myocardial schemia nthe 
presence ofsignificant a herosclerotic coronary narrowing or 
from the progression f a lesion in a diseased coronary artery. 
There has been considerable progress in our understanding 
of coronary artery disease since the previous task force report 
(7). The previous report considered as significant only those 
lesions producing HO% narrowing of the lumen diameter. 
Such lesions are regarded as “hemodynamically significant” 
because they often restrict oronary artery flow during periods 
of increased myocardial oxygen demand. It is now appreciated 
that he morphology of less evere atherosclerotic lesions can 
be rapidly altered by plaque rupture and thrombosis, leading to 
unstable angina, myocardial nfarction and death (8,9). Acute 
plaque rupture or thrombosis is present ina high proportion of
sudden cardiac deaths in the general population (9) and has 
also been documented in victims of exercise-related cardiac 
events (5,10,11). Consequently, such hemodynamically “non- 
significant” stenoses may increase the cardiac risk of exercise 
but frequently would not be suspected bypresently available 
